Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tazarotene gel in nail psoriasis
NCT02235480Phase 2Completed
- Sponsor
- Almirall
- Start
- Feb 2014
- Primary completion
- May 2014
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in nail psoriasis comparing Tazarotene Gel with Placebo Gel (2 arms). Primary endpoint: % reduction in the Nail Psoriasis Severity Index at Day 85. Started Feb 2014; status: completed.
02
Drugs
tazarotene
03
Conditions
nail psoriasis
Beyond the preview
Go deeper on NCT02235480.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02235480.